David D. Chang, President and CEO: Allogene Therapeutics ALLO Planned sale · Filed 02/02

Trade details

Type: Planned sale notice
Stock: Allogene Therapeutics ALLO
Person: David D. ChangPresident and CEO
Planned sale date: 26/02/02
Filed: 26/02/02

0.1% of shares outstanding to be sold

Allogene Therapeutics trades, last 26 weeks

What else happened in Allogene Therapeutics around then

Filed or reported within 30 days of the trade day · 01/03~03/04

David D. Chang's recent trades

David D. ChangPresident and CEO
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$118K
47,763 sh
$118K
Filed 03/18
Traded 03/16
David D. ChangPresident and CEO
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$117.8K
47,763 sh
$117.8K
Filed 03/16
Traded 03/16
David D. ChangPresident and CEO
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$171.5K
95,269 sh
$171.5K
Filed 02/04
Traded 02/02
David D. ChangPresident and CEO
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$91.5K
46,668 sh
$91.5K
Filed 25/03/18
Traded 25/03/14
David D. ChangPresident and CEO
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$91.5K
46,668 sh
$91.5K
Filed 25/03/14
Traded 25/03/14